pyrrolidine has been researched along with sq-23377 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, GE; Cherepanov, V; Degousee, N; Downey, GP; Gelb, MH; Ghomashchi, F; Glogauer, M; Grinstein, S; Harkin, DW; Kelvin, D; Koh, A; Lindsay, TF; Nallan, L; Plumb, J; Rubin, BB; Sadilek, M; Smart, BP; Stefanski, E; Sun, C; Vachon, E; Yaffe, MB | 1 |
1 other study(ies) available for pyrrolidine and sq-23377
| Article | Year |
|---|---|
Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activ
Topics: Animals; Arachidonic Acid; Bronchoalveolar Lavage Fluid; CD11b Antigen; Cytosol; Dose-Response Relationship, Drug; Escherichia coli; Group IV Phospholipases A2; Humans; Inflammation; Ionomycin; Leukotriene B4; Mice; Mice, Transgenic; NADPH Oxidases; Neutrophils; Oxygen; Phagocytosis; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pneumonia; Pyrrolidines; Receptors, IgG; Time Factors; Tumor Necrosis Factor-alpha | 2005 |